Government of Nova Scotia
Nova Scotia COVID-19 Vaccine Program: Information for Health Care Professionals (Evergreen Document) – Updated September 2, 2022
COVID-19 mRNA Vaccines: Summary of Use for Health Care Providers
Information about COVID-19 Vaccine Booster Doses (patient)
Guidance on Third Doses of COVID-19 Vaccine for Moderately to Severely Immunocompromised Nova Scotians
Primary Immunodeficiency: Eligibility for a Third Dose of COVID-19 Vaccine in Nova Scotia
Immunosupressive Medication List – Updated October 19, 2021
COVID-19 Vaccine Rollout Information
Direction on how to manage a vaccine error should it occur
Documentation Errors in CANImmunize Clinic Flow
Correction of Documentation Errors within CANImmunize Clinic Flow
NSCP Advisory
Registrar’s Advisory: Community Pharmacy Involvement in COVID-19 Vaccination
NSH COVID-19 Vaccine Pharmacist Consult Service
Nova Scotia Health’s (NSH) Pharmacy Department is launching the COVID-19 Vaccine Pharmacist Consult Service. This consult service will be available from 8:30 am until 4:30 pm, 7 days a week. You can reach this consult service by calling 1-833-768-1151. Please note: if calling outside of the scheduled hours, you will be directed to call the following day.
When calling, pharmacists will be directed to a NSH pharmacist who will:
- Answer vaccination consent category 1-3 questions and answer consent category 4-5 questions in collaboration with Vaccination Clinical Support Physicians (VACS)
- Answer storage, stability, and administration questions
- Provide general vaccine information
More information on the consult service can be found here.
Webinars
Building COVID-19 Vaccine Confidence Before, During and After Pregnancy (March 17, 2022)
Preparing for Pediatric COVID-19 Immunization and Adult Booster Doses (November 17, 2021)
Revaccination with COVID-19 Vaccines After Anaphylaxis (November 15, 2021)
Seasonal Influenza Immunization 2021-2022 (October 27, 2021)
COVID-19 Variants and Vaccines (June 23, 2021)
NACI Recommendations on COVID-19 Vaccine Interchangeability (June 21, 2021)
Addressing COVID-19 Vaccine Hesitancy in Clinical Practice (May 19, 2021)
Recommendation of the National Advisory Committee on Immunization (NACI) on Extended Dose Intervals for COVID-19 Vaccines (May 5, 2021)
COVID-19 Vaccine Emerging Issues Webinar: Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) (April 21, 2021)
COVID-19 Vaccines – Delayed Injection Site Reactions (March 11, 2021)
COVID-19 Vaccines – Planning for Immunization Clinics (March 1, 2021)
COVID-19 Vaccines Foundational Webinar (February 23, 2021)
COVID-19 Vaccines – Allergies, Anaphylaxis and LDV Syringe Discussion (February 10, 2021)
Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Moderna COVID-19 Vaccine (December 30, 2020)
Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Pfizer-BioNTech COVID-19 Vaccine (December 18, 2020)
COVID-19 Vaccine Foundations for Health Care Providers (December 14, 2020)
Health Canada
Quick Reference Guide on the Use of COVID-19 Vaccines for Youth and Adults (12 years and over)
Quick Reference Guide on the Use of COVID-19 Vaccines for Children 5 to 11 Years of Age
COVID-19 Vaccine Tool Kit for Health Care Providers – Updated May 7, 2021
Information for Health Care Providers on Allergies and Anaphylaxis Following Administration of COVID-19 Vaccines
COVID-19 Vaccines and Low Dead Volume (LDV) Syringes
Interim National Vaccine Storage, Handling and Transportation Guidelines for Ultra-Low Temperature and Frozen Temperature COVID-19 Vaccines
Pfizer-BioNTech
Adult Vaccine
Pfizer-BioNTech COVID-19 vaccine: What you should know (patient)
Pfizer Comirnaty Information about COVID-19 Vaccine Booster Doses
Important Information about Myocarditis and Pericarditis
Pfizer COVID-19 Vaccine Monograph Canada
Pfizer COVID -19 Vaccine Information Sheet (patient)
Pfizer Health Care Professionals Website
Pfizer-BioNTech COVID-19 vaccine: Information About Low Dead-Volume Syringes
Pediatric Vaccine
Pfizer COVID-19 Pediatric Vaccine Information Sheet (patient)
Pfizer Health Care Professionals Website – Updated November 19, 2021 for pediatric vaccine
Access to Canadian-specific labelling information during the distribution of Pfizer-BioNTech COVID-19 Vaccine for Children Aged 5 to Less Than 12 Years
Moderna
Moderna COVID-19 vaccine: What you should know (patient)
Moderna Spikevax Vaccines Information about COVID-19 Vaccine Booster Doses
Important Information about Myocarditis and Pericarditis
Moderna COVID-19 Vaccine Monograph Canada
Moderna Resources for Canadian Healthcare Professionals and Patients
Moderna COVID-19 Vaccine Information Sheet (patient)
Moderna COVID-19 Vaccine Storage and Handling
Importation of COVID-19 Vaccine Moderna with up to 15 Doses per Vial and English-only Vial and Carton Labels (US-Labelled Vaccine Supply)
AstraZeneca
AstraZeneca COVID-19 Vaccine: What you should know (patient)
AstraZeneca COVID-19 Vaccine Monograph Canada
AstraZeneca COVID-19 Information Sheet (patient)
PHAC Infobulletin on VITT for Health Care Providers
Access to Canadian-specific labelling information during the initial distribution of the AstraZeneca COVID-19 Vaccine (US-labelled vaccine supplies) (For April 6th Shipment ONLY)
Janssen
Janssen COVID-19 Vaccine Information Sheet (patient)
Janssen COVID-19 Vaccine: What you should know (patient)
Janssen COVID-19 Vaccine Monograph Canada
Medicago
Medicago COVID-19 Vaccine Monograph Canada
Centre for Effective Practice
COVID-19 Vaccines
USP
USP COVID-19 Vaccine Handling Toolkit